These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27827301)

  • 21. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
    Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
    Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
    [No Abstract]   [Full Text] [Related]  

  • 22. Potent and Selective Inhibitors of MTH1 Probe Its Role in Cancer Cell Survival.
    Kettle JG; Alwan H; Bista M; Breed J; Davies NL; Eckersley K; Fillery S; Foote KM; Goodwin L; Jones DR; Käck H; Lau A; Nissink JW; Read J; Scott JS; Taylor B; Walker G; Wissler L; Wylot M
    J Med Chem; 2016 Mar; 59(6):2346-61. PubMed ID: 26878898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualization of oxidized guanine nucleotides accumulation in living cells with split MutT.
    Fujikawa Y; Kawai H; Suzuki T; Kamiya H
    Nucleic Acids Res; 2024 Jun; 52(11):6532-6542. PubMed ID: 38738661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1.
    Lee Y; Onishi Y; McPherson L; Kietrys AM; Hebenbrock M; Jun YW; Das I; Adimoolam S; Ji D; Mohsen MG; Ford JM; Kool ET
    ACS Chem Biol; 2022 Aug; 17(8):2074-2087. PubMed ID: 35830623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures.
    van der Waals LM; Laoukili J; Jongen JMJ; Raats DA; Borel Rinkes IHM; Kranenburg O
    Sci Rep; 2019 Jan; 9(1):819. PubMed ID: 30692572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AuNP flares-capped mesoporous silica nanoplatform for MTH1 detection and inhibition.
    Gao W; Cao W; Sun Y; Wei X; Xu K; Zhang H; Tang B
    Biomaterials; 2015 Nov; 69():212-21. PubMed ID: 26298289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augment of Oxidative Damage with Enhanced Photodynamic Process and MTH1 Inhibition for Tumor Therapy.
    Hu JJ; Chen Y; Li ZH; Peng SY; Sun Y; Zhang XZ
    Nano Lett; 2019 Aug; 19(8):5568-5576. PubMed ID: 31262183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTH1 inhibitor amplifies the lethality of reactive oxygen species to tumor in photodynamic therapy.
    Zhao L; Li J; Su Y; Yang L; Chen L; Qiang L; Wang Y; Xiang H; Tham HP; Peng J; Zhao Y
    Sci Adv; 2020 Mar; 6(10):eaaz0575. PubMed ID: 32181355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and structure-activity relationship of purine derivatives as novel MTH1 inhibitors.
    Kumar A; Kawamura T; Kawatani M; Osada H; Zhang KYJ
    Chem Biol Drug Des; 2017 Jun; 89(6):862-869. PubMed ID: 27863017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Karonudib is a promising anticancer therapy in hepatocellular carcinoma.
    Hua X; Sanjiv K; Gad H; Pham T; Gokturk C; Rasti A; Zhao Z; He K; Feng M; Zang Y; Zhang J; Xia Q; Helleday T; Warpman Berglund U
    Ther Adv Med Oncol; 2019; 11():1758835919866960. PubMed ID: 31489034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MTH1 inhibition synergizes with ROS-inducing agents to trigger cervical cancer cells undergoing parthanatos.
    Li C; Xue Y; Wu J; Zhang L; Yang T; Ai M; Han J; Zheng X; Wang R; Boldogh I; Ba X
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167190. PubMed ID: 38657912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
    Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
    Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
    Yokoyama T; Kitakami R; Mizuguchi M
    Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Existence of MTH1-independent 8-oxodGTPase Activity in Cancer Cells as a Compensatory Mechanism against On-target Effects of MTH1 Inhibitors.
    Samaranayake GJ; Troccoli CI; Zhang L; Huynh M; Jayaraj CJ; Ji D; McPherson L; Onishi Y; Nguyen DM; Robbins DJ; Karbaschi M; Cooke MS; Barrientos A; Kool ET; Rai P
    Mol Cancer Ther; 2020 Feb; 19(2):432-446. PubMed ID: 31744893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased MTH1-specific 8-oxodGTPase activity is a hallmark of cancer in colon, lung and pancreatic tissue.
    McPherson LA; Troccoli CI; Ji D; Bowles AE; Gardiner ML; Mohsen MG; Nagathihalli NS; Nguyen DM; Robbins DJ; Merchant NB; Kool ET; Rai P; Ford JM
    DNA Repair (Amst); 2019 Nov; 83():102644. PubMed ID: 31311767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of mutagenesis by 8-hydroxy-2'-deoxyguanosine 5'-triphosphate (7,8-dihydro-8-oxo-2'-deoxyguanosine 5'-triphosphate) by human MTH1, MTH2, and NUDT5.
    Hori M; Satou K; Harashima H; Kamiya H
    Free Radic Biol Med; 2010 May; 48(9):1197-201. PubMed ID: 20144704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiolabeled 6-(2, 3-Dichlorophenyl)-N4-methylpyrimidine-2, 4-diamine (TH287): A Potential Radiotracer for Measuring and Imaging MTH1.
    Chen H; Afrin S; Guo Y; Chu W; Benzinger TLS; Rogers BE; Garbow JR; Perlmutter JS; Zhou D; Xu J
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer therapy. Targeting the poison within.
    Smits VA; Gillespie DA
    Cell Cycle; 2014; 13(15):2330-3. PubMed ID: 25483183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
    Magkouta SF; Pappas AG; Vaitsi PC; Agioutantis PC; Pateras IS; Moschos CA; Iliopoulou MP; Kosti CN; Loutrari HV; Gorgoulis VG; Kalomenidis IT
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32554927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells.
    Aristizabal Prada ET; Orth M; Nölting S; Spöttl G; Maurer J; Auernhammer C
    PLoS One; 2017; 12(5):e0178375. PubMed ID: 28542590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.